Asked by Fierce if he’d consider…
Asked by Fierce if he’d consider returning to the FDA, [...]
Asked by Fierce if he’d consider returning to the FDA, [...]
A chemist, she lent her expertise in drug research to [...]
Researchers at the University of Pittsburgh gave transplant recipients certain [...]
The agreement fulfills several ambitions for UCB. Besides building its [...]
More than a year after licensing its PD-1xVEGF bispecific, Merck [...]
The FDA should strengthen the evidence required for drug approvals [...]
Nationwide, hospitals and other providers are leaving private Medicare Advantage [...]
The recall affects only a small number of pills, sold [...]
Viatris and Teva Pharmaceutical Industries recently launched separate recalls related [...]
After its bet on a rare eye disease gene therapy [...]